BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19855253)

  • 1. Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.
    Pine SO; McElrath MJ; Bochud PY
    AIDS; 2009 Nov; 23(18):2387-95. PubMed ID: 19855253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression.
    Soriano-Sarabia N; Vallejo A; Ramírez-Lorca R; Rodríguez Mdel M; Salinas A; Pulido I; Sáez ME; Leal M
    J Acquir Immune Defic Syndr; 2008 Oct; 49(2):128-35. PubMed ID: 18769358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.
    Said EA; Al-Yafei F; Zadjali F; Hasson SS; Al-Balushi MS; Al-Mahruqi S; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
    Immunol Lett; 2014 Jul; 160(1):58-64. PubMed ID: 24747071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.
    Bochud PY; Hersberger M; Taffé P; Bochud M; Stein CM; Rodrigues SD; Calandra T; Francioli P; Telenti A; Speck RF; Aderem A;
    AIDS; 2007 Feb; 21(4):441-6. PubMed ID: 17301562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy.
    Vallejo A; Molina-Pinelo S; de Felipe B; Abad-Fernández M; González-Escribano MF; Leal M; Soriano-Sarabia N
    J Acquir Immune Defic Syndr; 2020 Oct; 85(2):252-256. PubMed ID: 32658127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women.
    Wujcicka W; Paradowska E; Studzińska M; Wilczyński J; Nowakowska D
    Virol J; 2017 Mar; 14(1):64. PubMed ID: 28340580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of genetic variability in toll-like receptors (TLR 2, TLR 4, and TLR 9) on human immunodeficiency virus-1 disease progression.
    Kaushik G; Vashishtha R
    Int J Mycobacteriol; 2023; 12(1):10-16. PubMed ID: 36926756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.
    Bochud PY; Chien JW; Marr KA; Leisenring WM; Upton A; Janer M; Rodrigues SD; Li S; Hansen JA; Zhao LP; Aderem A; Boeckh M
    N Engl J Med; 2008 Oct; 359(17):1766-77. PubMed ID: 18946062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.
    Spector SA; Qin M; Lujan-Zilbermann J; Singh KK; Warshaw MG; Williams PL; Jean-Philippe P; Fenton T; Siberry GK;
    Clin Vaccine Immunol; 2013 Jun; 20(6):900-6. PubMed ID: 23595505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of TLR4 (1063A/G and 1363C/T) polymorphisms in healthy and HIV-infected Omani individuals and their relationship to viral load and T cell count.
    Said EA; Al-Yafei F; Zadjali F; Al-Balushi MS; Hasson SS; Al-Mahroqi SH; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level.
    Beima-Sofie KM; Bigham AW; Lingappa JR; Wamalwa D; Mackelprang RD; Bamshad MJ; Maleche-Obimbo E; Richardson BA; John-Stewart GC
    AIDS; 2013 Sep; 27(15):2431-9. PubMed ID: 24037211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
    Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
    Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
    Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
    Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations within TLR genes in development of Toxoplasma gondii infection among Polish pregnant women.
    Wujcicka W; Wilczyński J; Nowakowska D
    Adv Med Sci; 2017 Sep; 62(2):216-222. PubMed ID: 28500897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents.
    Royse KE; Kempf MC; McGwin G; Wilson CM; Tang J; Shrestha S
    J Reprod Immunol; 2012 Dec; 96(1-2):84-9. PubMed ID: 23021866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Hamdy S; Osman AM; Zakaria ZA; Galal I; Sobhy M; Hashem M; Allam WR; Abdel-Samiee M; Rewisha E; Waked I; Abdelwahab SF
    Arch Virol; 2018 Sep; 163(9):2433-2442. PubMed ID: 29860675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Scott RJ
    BMC Cancer; 2010 Jul; 10():382. PubMed ID: 20646321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.
    Hong J; Leung E; Fraser AG; Merriman TR; Vishnu P; Krissansen GW
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1760-6. PubMed ID: 17914947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients.
    Joshi A; Punke EB; Mehmetoglu-Gurbuz T; Peralta DP; Garg H
    BMC Infect Dis; 2019 Jan; 19(1):56. PubMed ID: 30651082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.